On Friday, Merck & Co Inc (NYSE: MRK) was 0.40% up from the session before settling in for the closing price of $100.69. A 52-week range for MRK has been $73.31 – $105.84.
Healthcare Sector giant saw their annual sales surged by 12.04% over the last five years. When this article was written, the company’s average yearly earnings per share was at 17.26%. With a float of $2.48 billion, this company’s outstanding shares have now reached $2.49 billion.
Merck & Co Inc (MRK) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Merck & Co Inc stocks. The insider ownership of Merck & Co Inc is 0.10%, while institutional ownership is 79.82%. The most recent insider transaction that took place on Nov 10 ’25, was worth 616,395. In this transaction Chief Comm. & Public Afrs Ofcr of this company sold 7,085 shares at a rate of $87.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 10 ’25, when Company’s Officer proposed sale 7,085 for $87.00, making the entire transaction worth $616,395.
Merck & Co Inc (MRK) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 1.72 earnings per share (EPS) during the time that was better than consensus figure (set at 1.67) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.02% during the next five years compared to 12.04% growth over the previous five years of trading.
Merck & Co Inc (NYSE: MRK) Trading Performance Indicators
You can see what Merck & Co Inc (MRK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.93. Likewise, its price to free cash flow for the trailing twelve months is 19.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.56, a number that is poised to hit 2.05 in the next quarter and is forecasted to reach 8.37 in one year’s time.
Technical Analysis of Merck & Co Inc (MRK)
Analysing the last 5-days average volume posted by the [Merck & Co Inc, MRK], we can find that recorded value of 21.17 million was better than the volume posted last year of 14.79 million. As of the previous 9 days, the stock’s Stochastic %D was 73.66%.
During the past 100 days, Merck & Co Inc’s (MRK) raw stochastic average was set at 83.22%, which indicates a significant increase from 71.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.32 in the past 14 days, which was higher than the 2.09 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $92.95, while its 200-day Moving Average is $85.20. Now, the first resistance to watch is $102.15. This is followed by the second major resistance level at $103.22. The third major resistance level sits at $104.24. If the price goes on to break the first support level at $100.07, it is likely to go to the next support level at $99.05. Should the price break the second support level, the third support level stands at $97.98.
Merck & Co Inc (NYSE: MRK) Key Stats
There are 2,482,023K outstanding shares of the company, which has a market capitalization of 250.91 billion. As of now, sales total 64,168 M while income totals 17,117 M. Its latest quarter income was 17,276 M while its last quarter net income were 5,785 M.
